Institution profile

医療法人社団NEO NEOクリニック東京

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01C2408029 +6

Location

Prefecture
Tokyo
Address
東京都港区白金台3-14-4 LBビルディング6階

Plan classification

  • Class INot registered
  • Class IINot registered
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 医療法人清悠会認定再生医療等委員会
  • ICTA特定認定再生医療等委員会

Public score

37.5/ 100

A · Review level
10.0 / 30
B · Technologies
23.9 / 35
C · Coverage
3.6 / 25
D · Class I / II technologies
0.0 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 1378of 1736

Registered technologies
7
Areas covered
1

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 37.5
Public score →100

Registered technologies (7)

NK and immune cells 7
Registered technologies · Japanese originalTechnology areasPlan classification
ヒト自己活性化NK細胞によるがん免疫細胞療法NK and immune cellsClass III
ヒト自己活性化αβT細胞によるがん免疫細胞療法NK and immune cellsClass III
樹状細胞とリンパ球系細胞の共培養細胞によるがん免疫細胞療法NK and immune cellsClass III
胸水から増やした自己腫瘍内浸潤リンパ球(TIL)の胸腔内投与によるがん免疫細胞療法NK and immune cellsClass III
腹水から増やした自己腫瘍内浸潤リンパ球(TIL)の腹腔内投与によるがん免疫細胞療法NK and immune cellsClass III
胸腹水から増やした自己腫瘍内浸潤リンパ球(TIL)の点滴投与によるがん免疫細胞療法NK and immune cellsClass III
悪性腫瘍に対する樹状細胞ワクチンを用いた療法NK and immune cellsClass III

Certified committee for regenerative medicine

  • 医療法人清悠会認定再生医療等委員会
  • ICTA特定認定再生医療等委員会

Public document number

  • 01C2408029
  • 03C2209009
  • 03C2209010
  • 03C2209011
  • 01C2209044
  • 02C2508031
  • 02C2508029
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
悪性腫瘍に対する樹状細胞ワクチンを用いた療法Class III医療法人清悠会認定再生医療等委員会01C2408029
胸水から増やした自己腫瘍内浸潤リンパ球(TIL)の胸腔内投与によるがん免疫細胞療法Class IIIICTA特定認定再生医療等委員会03C2209009
腹水から増やした自己腫瘍内浸潤リンパ球(TIL)の腹腔内投与によるがん免疫細胞療法Class IIIICTA特定認定再生医療等委員会03C2209010
胸腹水から増やした自己腫瘍内浸潤リンパ球(TIL)の点滴投与によるがん免疫細胞療法Class IIIICTA特定認定再生医療等委員会03C2209011
樹状細胞とリンパ球系細胞の共培養細胞によるがん免疫細胞療法Class IIIICTA特定認定再生医療等委員会01C2209044
ヒト自己活性化αβT細胞によるがん免疫細胞療法Class IIIICTA特定認定再生医療等委員会02C2508031
ヒト自己活性化NK細胞によるがん免疫細胞療法Class IIIICTA特定認定再生医療等委員会02C2508029

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor